Royal DSM NV said its third-quarter normalized net income was €4.82 per share, compared with the S&P Capital IQ consensus estimate of 94 cents per share.
EPS rose 237.2% year over year from €1.43.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was €841.3 million, a gain of 235.5% from €250.8 million in the year-earlier period.
The normalized profit margin rose to 39.4% from 12.6% in the year-earlier period.
Total revenue increased 6.9% year over year to €2.14 billion from €2.00 billion, and total operating expenses grew 5.8% on an annual basis to €1.90 billion from €1.79 billion.
Reported net income increased 271.1% year over year to €1.28 billion, or €7.35 per share, from €346.0 million, or €1.97 per share.
